Aquestive therapeutics reports full year 2021 results exceeding revenue and ebitda guidance

Warren, n.j., march 08, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq:aqst), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today reported financial results for the fourth quarter and full year ended december 31, 2021, and provided an update on recent developments in its business.
AQST Ratings Summary
AQST Quant Ranking